TransMedics Group SEC filings

Filter: All · 8-K · 10-Q · 10-K · Form 4

10-QNov. 5, 2026, 4:10 p.m. ETView on SEC.gov
8-KNov. 5, 2026, 4:02 p.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedTransMedics Beats Q3 2026 Estimates With Adjusted EPS of $0.51 vs $0.29 Consensus and Raises FY2026 Revenue Guidance to $764-$774 Million
4Oct. 30, 2026, 4:15 p.m. ETView on SEC.gov
4Sept. 14, 2026, 4:30 p.m. ETView on SEC.gov
8-KSept. 10, 2026, 4:40 p.m. ETView on SEC.gov
Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits
4Aug. 17, 2026, 4:45 p.m. ETView on SEC.gov
10-QAug. 4, 2026, 4:15 p.m. ETView on SEC.gov
8-KAug. 4, 2026, 4:05 p.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits